CannaEvidence
Is this for me?
Is this for me?

Europe · all countries · model E — Cannabinoid medicines only

Medical cannabis in Lithuania

Registered cannabis-based medicines only, since 2019

Since 1 May 2019 Lithuania allows cannabis (a List I substance) only as an ingredient of a registered medicinal product; there is no programme for cannabis flower or extracts, so a new patient can only be prescribed an authorised cannabinoid medicine on a special narcotic prescription.

The hardest fact about Lithuania. Cannabis itself stays on List I ('prohibited'); the law's only medical exception is a medicinal product registered under Farmacijos įstatymas Art. 11 or listed in the Union register — cultivation of cannabis in Lithuania is banned outright (Art. 7).

Every answer below was read in the law, the register or the official statistic itself. This country is part of the Europe layer: an English page of verified facts, no directory. Where an answer is marked as not published, no official source states it — we did not fill the gap with a guess.

The questions, answered for Lithuania

How access works here

The one-line answer: can a new patient start today, and through what.

Model E — cannabinoid medicines only. Cannabis is a List I substance whose lawful circulation is prohibited except inside a registered medicinal product, in research, in law enforcement or as a laboratory reference standard.

Narkotinių ir psichotropinių medžiagų kontrolės įstatymas (Law on the Control of Narcotic and Psychotropic Substances), consolidated edition of 2025-11-01, Article 8(1): 'Vykdyti į I sąrašą įtrauktų medžiagų teisėtą apyvartą draudžiama, išskyrus atvejus, kai … 1) yra vaistinio preparato, įregistruoto vadovaujantis Farmacijos įstatymo 11 straipsnio 4 arba 5 dalyje, arba 11 straipsnio 8 dalyje, arba 11 straipsnio 10 dalyje, arba 11 straipsnio 15 dalyje nustatytais reikalavimais, arba registruoto vaistinio preparato, įrašyto į Sąjungos vaistinių preparatų registrą, sudėtyje'. Article 7 prohibits growing cannabis ('draudžiama auginti opijines aguonas, kanapes bei kokamedžius'). Latest amendment recorded on the article: Nr. XIV-162 of 2021-01-12; latest amendment of the law: XV-126, 2025-03-13. No named-patient cannabis route or flower programme exists in the law.

Source: Narkotinių ir psichotropinių medžiagų kontrolės įstatymas (Law on the Control of Narcotic and Psychotropic Substances), suvestinė redakcija 2025-11-01, PDF · read 27 September 2026

What may be prescribed

What the law allows a doctor to write on a prescription here.

Only medicinal products containing cannabis or cannabinoids that are registered in Lithuania or centrally in the EU (Epidyolex is centrally authorised). Whether Sativex or a dronabinol product is registered and marketed in Lithuania could not be confirmed from the VVKT register in this session. Cannabis flower, extracts and pharmacy compounding are not covered by any exception.

The Article 8(1)(1) exception covers products registered under Farmacijos įstatymas (Pharmacy Law) Art. 11 paragraphs 4, 5, 8, 10 or 15 or listed in the Union register of medicinal products. The VVKT (Valstybinė vaistų kontrolės tarnyba, State Medicines Control Agency) register search tool (vapris.vvkt.lt) is a client-side application and returned no data to this session, so the national registration status of Sativex/nabiximols and dronabinol is unverified. Industrial hemp products are regulated separately under the Pluoštinių kanapių įstatymas (Fibre Hemp Law).

Source: Narkotinių ir psichotropinių medžiagų kontrolės įstatymas, 8 straipsnis · read 27 September 2026

Who may prescribe

Whether you need a specialist, and whether anyone has to approve it first.

Any physician entitled to prescribe narcotic medicines; there is no list of authorised cannabis prescribers and no prior approval body. List II/III substances may be prescribed only for healthcare or veterinary purposes.

Article 17: 'Į II ir III sąrašus įtrauktos medžiagos gali būti skiriamos tik sveikatos priežiūros ar veterinarijos tikslams' and 'Asmuo pagal galiojantį receptą … turi teisę įsigyti vaistinėse į II ir III sąrašus įtrauktų paruoštos formos medžiagų'. No specialist restriction for cannabinoid medicines is stated in the law; product-level restrictions (e.g. Epidyolex specialist initiation) come from the product's authorisation, not from Lithuanian cannabis rules.

Source: Narkotinių ir psichotropinių medžiagų kontrolės įstatymas, 17 straipsnis · read 27 September 2026

Type of prescription

The form itself: which prescription, how long it is valid, how much it covers.

List II substances (THC-containing medicines) are prescribed on special prescription forms or through the national e-health system (e. sveikata); List III substances follow Ministry of Health procedure. Quantity and validity limits are set in the Ministry's prescription rules (Order No. 112 of 8 March 2002).

Article 18: 'Į II sąrašą įtrauktos medžiagos išrašomos receptuose naudojant specialiuosius receptų blankus arba elektroninėmis sveikatos sistemos priemonėmis'; 'Į III sąrašą įtrauktos medžiagos išrašomos Sveikatos apsaugos ministerijos nustatyta tvarka'. The detailed rules are in the Health Minister's Order Nr. 112 (2002-03-08) 'Receptų rašymo ir vaistinių preparatų, medicinos priemonių … išdavimo (pardavimo) vaistinėse … taisyklės' (Rules on writing prescriptions and dispensing medicinal products in pharmacies), referenced by VVKT; its validity/quantity provisions for narcotic prescriptions were not opened in this session.

Source: Narkotinių ir psichotropinių medžiagų kontrolės įstatymas, 18 straipsnis · read 27 September 2026

Telemedicine

Whether a prescription can lawfully begin in a video call.

Not published

Not published for cannabinoid medicines. Lithuania's e-health system supports electronic narcotic prescriptions, but no official rule found states whether a first prescription of a List II medicine may be issued after a remote consultation.

Article 18 allows List II prescriptions 'elektroninėmis sveikatos sistemos priemonėmis'. Remote-consultation rules sit in Ministry of Health orders that were not reachable in this session; no cannabis-specific statement exists.

Source: Narkotinių ir psichotropinių medžiagų kontrolės įstatymas, 18 straipsnis · read 27 September 2026

Dispensing

Which pharmacy can actually hand it over.

Licensed pharmacies dispense narcotic medicines against a valid prescription; sale to under-18s is prohibited; no compounding of cannabis and no mail order of narcotic medicines.

VVKT: 'Gyventojai narkotinius vaistinius preparatus gali įsigyti vaistinėse, turinčiose licenciją' and 'Vaistinėse draudžiama parduoti narkotinius ir psichotropinius vaistus vaikams iki 18 metų amžiaus'. The general rules on receiving medicines by post explicitly do not apply to narcotic/psychotropic medicines ('Šios taisyklės netaikomos narkotinių ir psichotropinių medžiagų turintiems vaistiniams preparatams').

Source: VVKT — Apie narkotinius ir psichotropinius vaistinius preparatus (About narcotic and psychotropic medicinal products) · read 27 September 2026

Reimbursement

Whether anyone other than you pays for it.

Not published

Not published for cannabinoid medicines. Whether any cannabis-based medicine is on the compensated medicines list of the Valstybinė ligonių kasa (National Health Insurance Fund) could not be verified in this session.

Lithuanian reimbursement requires inclusion in the Kompensuojamųjų vaistinių preparatų kainynas (price list of reimbursed medicines); no cannabinoid entry was checked. No regulator statement on reimbursement of cannabis medicines was found.

Source: Narkotinių ir psichotropinių medžiagų kontrolės įstatymas · read 27 September 2026

What it costs

What you pay, as far as anyone publishes it.

Not published

No public price verified. Prices of registered medicines are published in the VVKT register, which could not be queried in this session.

The VAPRIS register (vapris.vvkt.lt) lists registered products and pricing data but is a client-side application without static output.

Source: VVKT — Paieška vaistų registre (medicines register search) · read 27 September 2026

Driving

The question with the worst consequences and the least reliable information online.

Not published

Lithuania penalises driving under the influence of narcotic, psychotropic or other psychoactive substances without a numeric THC limit; no medical-use exemption is published. The operative articles of the Administracinių nusižengimų kodeksas (Code of Administrative Offences) could not be displayed in this session, so this is unverified.

The relevant provisions are in the Administracinių nusižengimų kodeksas (driving while intoxicated by narcotic, psychotropic or other psychoactive substances) and the Saugaus eismo automobilių keliais įstatymas (Road Traffic Safety Law). The e-TAR print link for the Code returned only metadata; the Road Traffic Safety Law could not be located without search. No THC threshold or prescription defence was verified.

Source: NTAKD — Teisės aktai (legal acts list; link to Administracinių nusižengimų kodeksas) · read 27 September 2026

Travel

Taking it across a border, which is where most published advice is simply wrong.

Within Schengen you may carry List II/III medicines for up to 30 days with the Art. 75 certificate from your country of residence; to or from non-Schengen countries, List II medicines for up to 15 days and List III for up to 30 days with copies of the prescriptions. Lithuanian residents get the certificate from a healthcare institution under Order V-138.

Article 20(1): 'Asmenys, vykstantys į Šengeno valstybę ar atvykstantys iš jos, gali vežtis gydymo tikslais asmeniniam vartojimui skirtų į II ir III sąrašus įtrauktų medžiagų ne ilgesniam kaip 30 dienų laikotarpiui, jeigu jie su savimi turi valstybės, kurioje gyvena, kompetentingos institucijos išduotą nustatytos formos pažymą.' Article 20(2): non-Schengen — List II 'ne ilgesniam kaip 15 dienų', List III 'ne ilgesniam kaip 30 dienų', with 'receptų … kopijas arba nuorašus'. The Lithuanian certificate is issued by an 'asmens sveikatos priežiūros įstaiga' under the Health Minister's Order of 2007-03-02 Nr. V-138. Cannabis flower is a List I substance and is not covered by these traveller allowances; only List II/III medicines are.

Source: Narkotinių ir psichotropinių medžiagų kontrolės įstatymas, 20 straipsnis (Keliaujančių asmenų teisės — travellers' rights) · read 27 September 2026

As a visitor or new resident

Four things nobody publishes together: getting a prescription as a non-resident, using a prescription from another EU country, bringing your own medicine in, and whether a foreign video consultation counts.

Nothing in the law limits prescribing of authorised cannabinoid medicines to residents, but the practical route is a Lithuanian doctor and a special/e-prescription. A prescription from another EU country is dispensable in Lithuania except for narcotic medicines, so THC products on a foreign prescription cannot be bought here; bring your own List II/III medicine within the traveller allowances instead.

1) Non-residents: no residency condition appears in Articles 17–18; the special narcotic prescription form or e-health prescription requires a Lithuanian-licensed prescriber — practical gate, not published as a legal bar. 2) Foreign EU/EEA prescriptions: the Health Minister's Order Nr. 112 (Rules on writing prescriptions and dispensing), points 102–102¹, implements Directive 2011/24/EU Art. 11 and Directive 2012/52/EU (from 25 October 2013): pharmacies may dispense on a paper or electronic prescription from another member state containing the required elements 'receptinius vaistinius preparatus, išskyrus narkotinius vaistinius preparatus' — narcotic medicines are excluded (Art. 11(6)); point 103 excludes 'narkotinius ir psichotropinius vaistinius preparatus' on prescriptions from non-EU countries. 3) Bringing medicine in: Article 20 — Schengen: List II/III up to 30 days with Art. 75 certificate; non-Schengen (UK, Ireland, non-EU): List II up to 15 days, List III up to 30 days, with prescription copies; no separate import permit is described for personal quantities. 4) Foreign telemedicine prescriptions: follow 2) — dispensable only for non-narcotic medicines; an e-prescription from another EU state must carry the Order 112 elements, and THC products are excluded.

Source: VVKT — Informacija apie elementus, įtrauktinus į receptus, kurie išrašomi kitoje valstybėje narėje (elements of prescriptions issued in another member state; Order Nr. 112 points 102–103) · read 27 September 2026

What is changing

What is pending in parliament or at the regulator, with dates — or the statement that nothing is.

Not published

The law in force (edition of 1 November 2025, last amended 13 March 2025) still allows cannabis only inside registered medicines. Reports of 2024 Seimas proposals to widen medical cannabis access could not be verified against the parliament's register in this session.

Consolidated law edition 2025-11-01; latest amending act XV-126 (2025-03-13); Article 8 last amended by XIV-162 (2021-01-12). No pending cannabis-flower or programme provision appears in the text. The Seimas bill register (e-seimas) returned 'object not found' for the IDs tried, so the status of any 2024 medical-cannabis bill is unknown.

Source: Narkotinių ir psichotropinių medžiagų kontrolės įstatymas, suvestinė redakcija 2025-11-01 · read 27 September 2026

Number of patients

How many people this actually concerns — where anyone counts.

Not published

No official count of patients on cannabis-based medicines is published by VVKT, NTAKD or the Ministry of Health as far as could be found.

VVKT's narcotic-medicines page and NTAKD's pages carry no patient or volume statistics for cannabinoid medicines.

Source: VVKT — Apie narkotinius ir psichotropinius vaistinius preparatus · read 27 September 2026

What we can publish for Lithuania, and what we cannot

Four directories, four honest answers. Where an official register exists we republish it and link every entry back to the source. Where none exists, that is what the page says — a list built out of self-declarations would be worse than no list, and saying so is more useful to you than pretending.

Doctors

No list — by design

No register of cannabinoid prescribers; the general licence register of physicians does not indicate who prescribes cannabis-based medicines.

Pharmacies

No list — by design

Any licensed pharmacy may dispense a registered narcotic medicine; no register marks cannabis dispensing.

Products and preparations

No list — by design

No cannabis-specific product list exists; registered medicines are in the VVKT register (vapris.vvkt.lt), which does not flag cannabinoids and could not be queried in this session.

Telemedicine platforms

No list — by design

No official telehealth register; no published rule on remote first prescriptions of List II medicines.

Where this country's law lives

Everything above comes from these texts rather than from another portal's summary. They are listed so you can check us.

Crossing a border with this

Two European rules decide most of what a traveller asks. Directive 2011/24/EU obliges pharmacies to honour prescriptions from another Member State — but only for medicines authorised in the dispensing country, and its Article 11(6) says the rule “shall not apply to medicinal products subject to special medical prescription”, which is where narcotic prescriptions sit. A magistral cannabis preparation is neither authorised nor outside that exclusion, so a cannabis prescription from another country is, as a rule, not dispensable anywhere in Europe. For carrying your own medicine, Article 75 of the Schengen Convention lets a resident of a Schengen state travel with a certified supply for up to 30 days; outside Schengen, national import rules apply. The country-specific answer is above under “As a visitor or new resident”.

Directive 2011/24/EU, Article 11(1) and 11(6) — read on EUR-Lex on 27 September 2026: CELEX 32011L0024.

Other countries with the same model (cannabinoid medicines only)

The answers change at every border, and a prescription does not travel with you. Compare before you assume.